"The actual product in our
case — the ingestible sensor technology — they're not reimbursed. We're at a
tailor-made moment right now with the need to social distance and continue to
care for the elderly that need to be on drugs."
— George Savage, chief medical officer and co-founder of Proteus
Digital Health, spoke with AIS's RADAR
on Drug Benefits about why the company made the decision to file
for bankruptcy protection amid disputes over reimbursement of their products.
No comments:
Post a Comment